inprens

Morepen Laboratories Limited

NSE:MOREPENLAB   MOREPEN LABORATORI
PROS

Company has reduced debt.
Company is almost debt free.
Company is expected to give good quarter
Company has delivered good profit growth of 41.36% CAGR over last 5 years
Promoter holding has increased by 3.84% over last quarter.

CONS

Stock is trading at 5.40 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.